KROS NASDAQ
Keros Therapeutics, Inc.
1W: -2.2%
1M: +1.2%
3M: +3.0%
YTD: -38.7%
1Y: -25.6%
3Y: -64.5%
5Y: -65.6%
$11.36
+0.10 (+0.89%)
Weekly Expected Move ±4.8%
$10
$11
$11
$12
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — KROS
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (21)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 60.0 | 62.1 | 59.6 | 60.5 | SEC ↗ |
| 2026-03-31 | 10-Q | 59.6 | 62.2 | 59.6 | 60.5 | SEC ↗ |
| 2025-12-31 | 10-K | 60.6 | 62.9 | 60.5 | 61.3 | SEC ↗ |
| 2025-09-30 | 10-Q | 59.7 | 62.2 | 60.0 | 60.7 | SEC ↗ |
| 2025-06-30 | 10-Q | 60.1 | 61.8 | 59.3 | 60.4 | SEC ↗ |
| 2025-03-31 | 10-Q | 58.3 | 61.3 | 59.9 | 59.9 | SEC ↗ |
| 2024-12-31 | 10-K | 60.0 | 62.7 | 59.5 | 60.7 | SEC ↗ |
| 2024-09-30 | 10-Q | 58.2 | 60.7 | 59.6 | 59.5 | SEC ↗ |
| 2024-06-30 | 10-Q | 57.1 | 60.9 | 59.9 | 59.3 | SEC ↗ |
| 2024-03-31 | 10-Q | 57.0 | 60.9 | 58.8 | 58.9 | SEC ↗ |
| 2023-09-30 | 10-Q | 58.3 | 61.5 | 60.0 | 59.9 | SEC ↗ |
| 2023-06-30 | 10-Q | 58.0 | 61.5 | 61.6 | 60.3 | SEC ↗ |
| 2023-03-31 | 10-Q | 58.4 | 61.0 | 60.1 | 59.8 | SEC ↗ |
| 2022-12-31 | 10-K | 59.0 | 62.2 | 60.4 | 60.5 | SEC ↗ |
| 2022-06-30 | 10-Q | 60.5 | 62.9 | 60.6 | 61.3 | SEC ↗ |
| 2021-12-31 | 10-K | 59.8 | 63.7 | 61.1 | 61.5 | SEC ↗ |
| 2021-06-30 | 10-Q | 59.9 | 62.2 | 60.2 | 60.8 | SEC ↗ |
| 2021-03-31 | 10-Q | 59.5 | 62.5 | 59.6 | 60.5 | SEC ↗ |
| 2020-09-30 | 10-Q | 60.5 | 63.2 | 61.9 | 61.8 | SEC ↗ |
| 2020-06-30 | 10-Q | 57.2 | 63.5 | 61.6 | 60.8 | SEC ↗ |
| 2020-03-31 | 10-Q | 57.4 | 62.4 | 60.1 | 60.0 | SEC ↗ |